摘要
目的:探讨高龄股骨粗隆间骨折患者使用股骨近端防旋髓内钉和动力髋螺钉治疗的效果。方法:选取2016年1-12月在本院接受治疗的高龄股骨粗隆间骨折患者100例,其中采用动力髋螺钉治疗的患者50例作为对照组,采用动力髋螺钉治疗的患者50例作为研究组。比较两组手术一般情况、临床治疗效果及术后并发症情况。结果:研究组术中出血量显著少于对照组(P<0.05),手术时间、骨性愈合时间、负重时间及住院时间均显著短于对照组(P<0.05)。研究组优良率为72.00%显著优于对照组的56.00%(P<0.05),且研究组术后髋关节Harris评分显著高于对照组(P<0.05)。研究组术后并发症发生率为4.00%显著低于对照组的20.00%(P<0.05)。结论:在高龄股骨粗隆间骨折患者治疗中选择股骨近端防旋髓内钉可有效提高治疗效果,术中损伤较小,术后恢复快,且安全性高,值得临床推广使用。
Objective:To investigate the effect of proximal femoral nail and dynamic hip screw in the treatment of elderly patients with femoral intertrochanteric fracture.Method:100 cases of elderly patients with femoral intertrochanteric fracture from January 2016 to December 2016 in our hospital were selected,50 cases treated with dynamic hip screw patients as the control group,50 cases treated with dynamic hip screw as the study group.The general surgery situation,clinical treatment and postoperative complications of two groups were compared.Result:The amount of intraoperative bleeding of the study group was significantly less than that of the control group(P0.05),the operation time,bone healing time,weight-bearing time and hospital stay of the study group were significantly shorter than those of the control group(P0.05).The excellent and good rate of the study group was 72.00%,and the control group was 56.00%,the excellent and good rate of the study group was significantly better than that of the control group(P0.05),the postoperative Harris hip score of the study group was significantly higher than that of the control group(P0.05).The incidence of postoperative complications of the study group was 4.00%,and the control group was 20.00%,the incidence of postoperative complications of the study group was significantly lower than that of the control group(P0.05).Conclusion:The elderly patients with femoral intertrochanteric fracture in the treatment of choice of proximal femoral nail anti rotation can effectivelyimprove the treatment effect,less damage to the patients,rapid postoperative recovery,and high safety,it is worthy of promotion in clinical use.
出处
《中国医学创新》
CAS
2017年第29期49-52,共4页
Medical Innovation of China